Overview
Praxis Precision Medicine is a clinical-stage biopharmaceutical company developing small molecule therapies targeting ion channel disorders of the brain, including epilepsy and essential tremor.
More in Neuropharmaceuticals
Latest industry news
Excellent Brain Partners With Scholas Occurrentes to Bring ADHD Neurofeedback Into Schools Worldwide
2026-10-06 · Industry
Tether Evo Targets the Longevity Problem at the Heart of Brain-Computer Interfaces
2026-10-05 · Research
Tianjin University Unveils a 3-Gram Non-Invasive BCI That Disappears Into Your Hair
2026-10-04 · Research
Neuralink Pretrained on 50,000 Hours of Unlabeled Brain Data — and the Implications Are Enormous
2026-10-03 · Research
Company details
Category
💊 Neuropharmaceuticals
Location
Cambridge, Massachusetts, USA
Funding
Publicly traded — NASDAQ: PRAX
Website
www.praxismedicines.comListed
2026-10-05
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →